| Therapeutic potential of pharmacological targeting NLRP3 inflammasome complex in cancer G Tezcan, EE Garanina, M Alsaadi, ZE Gilazieva, EV Martinova, ... Frontiers in immunology 11, 607881, 2021 | 27 | 2021 |
| Doxycycline attenuates cancer cell growth by suppressing NLRP3-mediated inflammation M Alsaadi, G Tezcan, EE Garanina, S Hamza, A McIntyre, AA Rizvanov, ... Pharmaceuticals 14 (9), 852, 2021 | 15 | 2021 |
| Long term immune response produced by the SputnikV vaccine E Martynova, S Hamza, EE Garanina, E Kabwe, M Markelova, ... International Journal of Molecular Sciences 22 (20), 11211, 2021 | 11 | 2021 |
| Rab GTPase mediating regulation of NALP3 in colorectal cancer G Tezcan, EE Garanina, MN Zhuravleva, S Hamza, AA Rizvanov, ... Molecules 25 (20), 4834, 2020 | 10 | 2020 |
| Immunogenic SARS-CoV-2 S and N protein peptide and cytokine combinations as biomarkers for early prediction of fatal COVID-19 E Martynova, S Hamza, M Markelova, E Garanina, Y Davidyuk, ... Frontiers in Immunology, 12, 2022 | 7 | 2022 |
| Antibody and T cell immune responses to SARS-CoV-2 peptides in COVID-19 convalescent patients E Garanina, S Hamza, RJ Stott-Marshall, E Martynova, M Markelova, ... Frontiers in Microbiology 13, 842232, 2022 | 5 | 2022 |
| Identification of conserved immunogenic peptides of SARS-CoV-2 nucleocapsid protein J Verma, N Kaushal, M Manish, N Subbarao, V Shakirova, E Martynova, ... Journal of Biomolecular Structure and Dynamics, 1-17, 2023 | 1 | 2023 |
| Blocking the Hormone Receptors Modulates NLRP3 in LPS-Primed Breast Cancer Cells S Hamza, EE Garanina, M Alsaadi, SF Khaiboullina, G Tezcan International journal of molecular sciences 24 (5), 4846, 2023 | 1 | 2023 |
| Azithromycin and ceftriaxone differentially activate NLRP3 in LPS primed cancer cells G Tezcan, M Alsaadi, S Hamza, EE Garanina, EV Martynova, ... International Journal of Molecular Sciences 23 (16), 9484, 2022 | 1 | 2022 |
| Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer S Hamza, EE Garanina, L Shkair, M Alsaadi, SF Khaiboullina, G Tezcan Pharmaceuticals 17 (3), 299, 2024 | | 2024 |
| Neutralizing Antibodies in COVID-19 Serum from Tatarstan, Russia S Hamza, E Martynova, E Garanina, V Shakirova, A Bilalova, S Moiseeva, ... International Journal of Molecular Sciences 24 (12), 10181, 2023 | | 2023 |
| Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ER alpha S Hamza, EE Garanina, SF Khaiboullina, G Tezcan CELL DEATH DISCOVERY 8, 2-2, 2022 | | 2022 |
| Tamoxifen reduces hepatocyte growth factor secretion in breast cancer cells with high NLRP3 expression S Hamza, E Garanina, M Alsaadi, G Tezcan, A Rizvanov, S Khaiboullina EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 52, 2022 | | 2022 |
| PRIMING OF NLRP3 INFLAMMASOME ACTIVATION MEDIATES TAMOXIFEN RESISTANCE IN BREAST CANCER S Hamza, EE Garanina, G Tezcan, SF Khaiboullina Биосистемы: организация, поведение, управление, 245-245, 2022 | | 2022 |
| Antibody Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients S Hamza, EE Garanina, EV Martynova, MI Markelova, JN Davidyuk, ... Фундаментальные и прикладные исследования по приоритетным направлениям …, 2022 | | 2022 |
| Prolonged immune response induced by sputnik V vaccine S Hamza, E Martynova, E Garanina, E Kabwe, M Markelova, V Shakirova, ... European Journal of Clinical Investigation, 1-1, 2022 | | 2022 |
| Trapping miR-223 leads to overexpression of NLRP3 in colorectal cancer S Hamza, EE Garanina, G Tezcan, AA Rizvanov, SF Khaiboullina HUMAN GENE THERAPY 32 (19-20), A126-A126, 2021 | | 2021 |
| Rab GTPase mediating regulation of NALP3 in colorectal cancer EE Garanina, MN Zhuravleva, S Hamza, AA Rizvanov, SF Khaiboullina MDPI, 2020 | | 2020 |
